Dotted horizontal lines indicate the thresholds corresponding to the complexes in the top 10 and top 50, after weight optimizations. Columns two and three show the accession codes of the corresponding PDB entries and the ORF IDs of the different yeast proteins in the given complex, respectively. Column 4 contains the feasibility score of the complex when ranking the 39 yeast complexes of known 3D structure together with the 491 complexes defined by Gavin et al., 2006 , and column 5 depicts the corresponding rank. 
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Figure S1. Experimental validation of complexes Experimental validation of the complexes was based on tandem affinity purification. To test the existence of a potential complex in vivo, we used several yeast strains; each with expression of the TAP tagged protein from the complex. Tandem affinity purification of TAP tagged proteins was prepared in native conditions, which allows for co-purification of all other proteins forming a complex. In the top left panel of each page, the results from independent purifications of all proteins forming a potential assemble are presented. Proteins from 5 fractions obtained during TAP purification (1; IgG SDS eluate, 2; Calmodulin SDS eluate, 3; IgG eluate, 4; Calmodulin flow, 5; Calmodulin eluate) were separated on 4-12 % gradient SDS-PAGE gels. Proteins were visualized with Coomassie staining. Protein bounds marked with numbers and proteins from the IgG eluate were analyzed with the use of mass spectrometry. Identified proteins were listed below, together with the obtained score. To conclusively validate a complex, all its components should be visible in gel, in a calmodulin eluate fraction, or at least identified by mass spectrometry in an IgG eluate. To check the expression of TAP tagged proteins, their stability and strength of binding to IgG, western blots were prepared. Total proteins from yeast extracts (1) -NTA chromatography: "FT", flow through, "0", "50", "100", "200" correspond to washes with standard buffer, including imidazole added to the concentration indicated (in mM). Each protein (Paa1, above and Ptc2, below, labelled at left with an arrow to denote the protein of interest) were expressed at both 15°C and 37°C (indicated with bars above the gel). The proteins were soluble at both of these temperatures. Molecular weight markers and their sizes are indicated to the right of all gels. Panel B: Complex Reconstitution between Paa1 and Ptc2 using a Superdex 75 10/30 (GE Healthcare) gel filtration chromatography. Control fractionations of either Paa1, injected alone (grey dotted line) or Ptc2 alone (grey solid line) eluted later than the more excluded Ptc2-Paa1 complex (solid black line). SDS-PAGE of selected fractions from a 96-well fraction collector are shown below the chromatogram (280 nm absorbance). The lanes compare the injected sample (INJ), as well as the peak fractions (D6-E7), demonstrating the presence of both proteins in the shifted peak. -NTA chromatography: "FT", flow through, "0", "50", "100", "200" correspond to washes with standard buffer, with imidazole added to the concentration indicated (in mM). Each protein (Gcd10, above and Gcd14, below, (labelled as in Supp. Fig. 3) , and both were soluble at both of these temperatures. Molecular weight markers and their sizes are indicated at right. Panel B: It was not possible to purify Gcd10 or Gcd14 in a non-aggregated form singly, so cells expressing each of the proteins alone (Gcd10 and Gcd14, as used in panel A), were combined and sonicated together after being resuspended in a buffer containing 1M NaCl and purified using Ni 2+ -NTA chromatography as in panel A. Fractions containing Gcd10 and Gcd14 were then loaded onto a Superdex S200 10/30 column, yielding a single, symmetrical peak containing both proteins. Estimation of the molecular weight of the complex by comparison with the elution volumes of molecular weight standards ferritin (440 kDa), beta-amylase (200 kDa) and aldolase (158 kDa) (arrowed) indicates that the complex is of approximately 300 kDa. -NTA chromatography purifications of coexpressed Gcd10/Gcd14 (Panel A) and Ssl2/Yor352w (Panel B) as synthetic, codonoptimized genes (above), compared to the naturally-occurring yeast DNA sequences (below). Fractions are labelled as follows: "T", total cells prior to sonication; "P", pellet post-sonication, "S"; supernatant post-sonication, "FT"; flow through, "E1" & "E2" are specific elutions with buffer including 300 mM imidazole. Note the increased yield when using codon-optimized genes in both cases. 
Supplemental Experimental Procedures
Algorithms for the selection of complexes using bioinformatics
We have already described a selection system to rank protein assemblies based on various parameters (Pache and Aloy, 2008) , but recapitulate it here. The algorithm is based on the notion that promising target complexes should be small, compact and homogeneous in order to yield successful expression, purification and structure determination. To rank the complexes, biophysical, biochemical and large-scale proteomics data are incorporated in the form of partial scoring functions that we then normalized and combined into a final feasibility score for each complex.
Briefly, the first individual score refers to the average socio-affinity index of the complex (Gavin et al., 2006) , which quantifies the tendency of two proteins to interact with each other when tagged and to co-purify when yet other proteins are tagged. The higher the average socio-affinity of a complex, the more of its proteins are predicted to be in direct contact, which could be used as an indication for the compactness of the complex. We also consider the molecular weight and the total sequence length of the complex components, since larger proteins are usually more difficult to express. We penalize the presence of low complexity regions, internal repeats, coiled coils and intrinsically disordered stretches, since they often result in insoluble proteins that aggregate when over-expressed (Dale et al., 2003) .
Information regarding sub-cellular localization and abundance (Ghaemmaghami et al., 2003) of individual proteins is also considered, since complex components are expected to be consistent in these terms. Another criterion employed is the level of conservation of a complex across evolution, which we addressed by considering orthologous protein relationships in 83 eukaryotic species (von Mering et al., 2007) . We also used binary interactions extracted from yeast two-hybrid screens in combination with the number of isoforms described for each complex to estimate its self-consistency. This is to capture the independence and homogeneity of each complex with respect to the others. For instance, if a complex contains many binary interactions between its own subunits and few with proteins from other complexes, this decreases the probability of missing components in the definition of the complex. Additionally, the fewer isoforms the more invariant the protein cluster is. Finally, we used cumulative probabilities to normalize each score to the range [0,1], and calculated a global feasibility score as the weighted average of all normalized partial scores. The final score S(c) assigned to each protein complex c is calculated by taking the weighted average of all normalized partial scores s i (c), ignoring those which are not applicable for the respective protein complex (e.g. the 'Average abundance ratio' when the abundance of none of the proteins in the respective complex could be determined), and multiplying by 100.
Using a weighted average to combine all partial scores makes it possible to
give each partial score a particular weight w i , which allows us to evaluate its importance and to control its impact on the final score:
denotes the cumulative probability that the partial score s i (c) of the protein complex c is equal to x , and is used to account for the distribution of each partial score. This cumulative probability needs to take into account if lower or higher values are more favorable for each partial score (e.g. a good "average socio-affinity" has a high value, while a good value for the average of "problematic residues" should be low) and is calculated as follows: 
Cloning into T7 promoter-based expression systems Cloning strategy used for single-subunit expression
For the expression and production of single proteins, a cloning strategy to generate C-terminally 6His-tagged proteins was employed. In order to minimize the possibility that errors could be introduced into the primers, to test for the presence of restriction sites in the gene, and to find optimal melting temperatures for primer pairs, a web interface-based script was written. The web interface is part of a basic laboratory information management system (LIMS), which additionally allows the storage of the primers in a structured query language (SQL) database. The software is open source, and freely available: http://plasmidb.sourceforge.net.
PCR reactions were performed with oligonucleotides which encoded either a 5´ Nco I or Nde I restriction site (the choice of restriction site was determined by the absence of this restriction site in the gene of interest), and a 3´ primer which contains a Not I site, followed by a sequence encoding a 6His tag and a stop codon. The oligonucleotides used in this study are listed in Supplemental Table 1 . PCR using these primers and Saccharomyces cerevisiae S288C genomic DNA as template yielded DNA fragments of the expected size for all of the desired genes, except for Ste11, which we were unable to produce. The resulting PCR products that encoded a 5´ Nde I site were cloned into the vector pET9 (Novagen), and those containing Nco I sites were cloned into pET28 (Novagen), using standard procedures. Since it was not possible to obtain a PCR product of Ste11, despite numerous attempts with different primers and melting temperatures, the gene encoding Ste11 was ordered as a synthetic gene.
Cloning strategy used for multi-plasmid co-expression
The vector DNA pET-NKIb 3C/LIC (10µg) was digested with Kpn I (2-3h at 37°C; NEB) and purified with a QIAquick spin column (Qiagen) according to the manufacturer's protocol. The linearised vector was treated with T4 DNA Polymerase in the presence of 25 mM dTTP to generate single-strand overhangs. The reaction was incubated at room temperature for 30 min and inactivated by incubating at 75°C for 20 min. Target genes were amplified by PCR using the Pfu Turbo polymerase (Stratagene). For the pET-NKIb 3C/LIC the 5'-end of the primers must incorporate the CAGGGACCCGGT sequence upstream the forward PCR primer and the CGAGGAGAAGCCCGGTTA sequence upstream of the reverse primer (which includes a TAA stop codon). For the pET-NKIb LIC without a 6His-tag (no-tag constructs), the sequence GGGCCCGGCGATG must be incorporated in the 5'-end of the primers. A web server enabling the high throughput design of PCR primers was used and is freely available at http://xtal.nki.nl/ccd. The PCR products were purified prior to T4 treatment (QlAquick PCR purification kit by Qiagen); 0.2 pmol of purified PCR DNA was treated with T4 DNA Polymerase in the presence of 25 mM dATP to create the single-strand overhangs. The reaction was incubated at room temperature for 30 min and inactivated by incubation at 75°C for 20 minutes.
Annealing of the vector and insert was achieved by mixing 1 μl pET-NKIb 3C/LIC vector (50ng/μl) with 2 μl insert (0.02 pmol). The reactions were incubated at RT for 5 min, after which 1 μl of 25 mM EDTA was added. Typically, half of the annealing reaction (2µl) is transformed into NovaBlue competent cells (Novagen) and after overnight incubation at 37°C, the annealing and transformation efficiency can be verified. A typical transformation protocol was used (incubation on ice-20 min; heat shock-30 sec at 42°C; incubation on ice 2 min; addition of 80 μl LB medium to each sample and incubation at 37°C for 1 hour) and transformants are plated on LB agar supplemented with kanamycin (30mg/ml for all his-tag constructs) or ampicillin (100mg/ml; for all no-tag constructs) and incubated at 37°C overnight. Plasmid DNA was extracted from single colonies using a miniprep kit (Qiagen) and restriction digestion was used to verify the presence of the insert of interest.
Cloning strategy used for poly-cistronic expression
For operon constructions, oligonucleotides were designed to amplify coding regions by PCR. Oligonucleotides contained restriction sites selected to be unique in the final plasmid, allowing the simultaneous insertion of both ORFs in the plasmid vector pBS3021. Oligonucleotides contained in addition a Shine-Dalgarno sequence upstream of the second ORF and a sequence encoding a 6His tag fused in-frame upstream or downstream of one of the two ORFs. PCR fragments were inserted by standard cloning downstream of the T7 promoter of the pBS3021 expression vector. DNA purifications were performed on an EPmotion robot (Eppendorf) using a Macherey-Nagel mini-preparation kit followed by digestion and gel electrophoresis to ascertain the presence of the desired inserts. Inserted fragments were entirely sequenced to confirm the absence of PCR-induced mutations.
Expression testing Expression testing of individual subunits
The initial objective in this part of the study was to define expression conditions that gave optimal yields of soluble protein for each full-length protein. Therefore, each expression vector under study was initially transformed into both Rosetta pLysS (Novagen) and Gold (Stratagene) in a 24-well block (Corning, Inc.). After incubation overnight in 5 ml per well of 2x Yeast Tryptone (2YT hereafter) medium supplemented with 30 μg/ml kanamycin at 37°C, this pre-culture was used to inoculate 10 ml per well of similar media as the expression culture, again using 2YT broth supplemented with 30 μg/ml kanamycin. The volume of the inoculum used was adapted according to its OD 600 so as to obtain a starting optical density of 0.1 for the expression culture. This culture was incubated until the OD 600 reached ~1, then was separated into three 1ml aliquots, one for each of the expression temperatures under study: 37ºC, 28ºC and 15ºC. After the addition of IPTG to a final concentration of 0.5 mM, the cells were incubated either for 4 hours at 37ºC, or for 16-18 hrs for the inductions at 28ºC and 15ºC. Cells were harvested by centrifugation of the 24-well block at 5,300 rpm for 1 hour.
The pellets in each well were re-suspended with lysis buffer (20 mM TrisHCl, pH 7.5, 200 mM NaCl, 5mM β-mercaptoethanol). The 24-well block containing the cell suspension was sonicated with 1 mM benzonase, 4 times for 10 minutes, and then centrifuged at 5,300 rpm for 1 hour. The crude and clarified cell lysates were analyzed using SDS-PAGE (Table 1 , column labeled "Single subunit expression" and Supplemental Fig. 1 ). All proteins except for Ste11 could be produced in a soluble form. Expression from a construct corresponding to Ste11 did not yield soluble protein, however. An expressed band apparent in purifications at approximately the expected size of Ste11 was in fact identified by mass spectrometry of tryptic digest of this band as polymyxin resistance protein arnA (UniProt accession code; P77398), a common contaminant of purifications originating from E. coli.
Expression testing for multi-plasmid co-expression
Small-scale protein expression and solubility screening was carried out for single constructs of full-length proteins, for constructs of individual or combinations of domains as well as for co-expressions of partners. For the transformation of single plasmids, plasmid DNA was transformed into E. coli Rosetta2 (DE3) T1R. Single colonies were used for small-scale expression trials in a 24-well 'Deepwell' block (Corning). Each well contained 3ml LB media supplemented with kanamycin 30mg/ml. For the transformation of multiple plasmids to co-express complexes, plasmid DNA of the two partners of interest was transformed into Rosetta2 (DE3) T1R E. coli and plated onto LB agar plates supplemented with 30 mg/ml kanamycin and 100 mg/ml ampicillin. Single colonies were used for small-scale expression trials in a 24-well 'Deepwell' block. Each well contained 3 ml LB media supplemented with 30mg/ml kanamycin and 100 mg/ml ampicillin.
The 24-well block was incubated in a shaking incubator at 500 rpm until an OD 600 of about 0.6-0.8 had been attained, at which point the temperature was reduced to 16°C and the cultures were induced by the addition of IPTG to a final concentration of 1 mM. Incubation was continued for 16-18 hrs and cells were harvested by centrifugation of the Deepwell block at 4,000 rpm for 15 minutes. The pellets in each well were resuspended with lysis buffer (40% sucrose, 50 mM TrisHCl pH 7.5, 200 mM NaCl, 5mM β-mercaptoethanol, 4mg/ml lysozyme (Novagen), DNAse and PMSF). The 24-well block containing the cell suspension was incubated in a temperature controlled shaking incubator at 300 rpm, for 20 minutes at 10°C and then centrifuged at 4,000 rpm for 15 minutes. The clarified cell lysate was then mixed with 25 μl pre-equilibrated MagneHis Ni-beads (Promega) and incubated at 4°C for 30 minutes. The Magnetight HT96 stand (Novagen) was used to pull down the MagneHis beads. The magnetic beads were washed 3 times with 1 ml wash buffer (lysis buffer supplemented with 20 mM imidazole). Protein elution was performed by adding 30 μl elution buffer (wash buffer containing 400 mM imidazole) to each sample and eluted fractions were analyzed by SDS-PAGE.
Expression testing for polycistronic co-expression
Proteins were expressed in BL21(DE3) codon+ E. coli using auto-induction media (Studier, 2005) . Small scale (3 ml) or large scale (100-200 ml) cultures were performed. After overnight incubation at 25°C, cells were harvested. For small-scale cultures, lysis was performed with lysozyme and benzonase. After centrifugation, the supernatant was incubated with Ni-NTA beads for 1h at 4°C. After washing the column with equilibration buffer (50 mM Tris HCl pH7.4, 20 mM imidazole, 300 mM NaCl, 2 mM ß-mercaptoethanol, 0.2 % NP40, 10 % glycerol), proteins were eluted with 500 mM imidazole. For large-scale culture, pellets were washed with PBS and dissolved in 20 ml of equilibration buffer. Cells were lysed using a "Constant Cell Disruption System". After centrifugation, the supernatant was filtered and purified by chromatography on Ni 2+ -NTA (Akta system, Hitrap Ni 2+ 1 ml column volume). After washing with equilibration buffer, elution was performed with a linear gradient from 0 to 100% of elution buffer (50 mM Tris HCl pH 7.4, 500 mM imidazole, 300 mM NaCl, 2 mM ß-mercaptoethanol, 0.2% NP40, 10% glycerol). All eluates were analyzed by means of SDS-PAGE.
Complex Formation Trials Reconstitution of complexes from individually purified partners
We purified Paa1 and Ptc2 to approximate homogeneity using gel filtration and concentrated them individually to 2 mg/ml. The two proteins were combined in a 500 μl reaction mixture (250μl of each component), and were incubated on ice at 4°C. Gel filtration chromatography illustrated that the proteins co-elute, shifting the peak of Ptc2 by 1.3 ml upon addition of the Paa1 subunit (Supplemental Fig. 3) . In a similar manner to the Paa1-Ptc2 complex, both Vps27 and Hse1 could be produced in a soluble form, and the proteins were produced using expression at 37°C henceforth (Supplemental Fig. 4 , Panel A). Vps27 and Hse1 proteins were purified to homogeneity using a final gel filtration step. 10nM of each of the proteins were injected separately into an S200 analytical column. Both proteins were then combined and incubated for 30 minutes at 4°C and subjected to gel filtration (Supplemental Fig.  4, Panel B) . The complex eluted at 11.03 ml, compared to the individual profiles of Vps27 (11.67 ml) and Hse1 (13.58 ml). Both proteins appear to be in the peak fractions, as judged by SDS-PAGE (Supplemental Fig. 4 , lower Panel A). Gcd10 and Gcd14 posed severe problems when purified individually, even from refolded material. Despite being able to obtain both proteins in a relatively soluble form (Supplemental Fig. 5 , Panel A), they had a tendency to aggregate as judged by their
